During the past decade, Covance CRU Inc. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Covance CRU Inc." #1 sponsor was "Mannkind Corporation" with 3 trials, followed by "Pfizer" with 2 trials sponsored, "AstraZeneca" with 1 trials sponsored, "Avigen" with 1 trials sponsored and "MedImmune LLC" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Covance CRU Inc." #1 collaborator was "Analytisch-biologisches Forschungslabor GmbH" with 1 trials as a collaborator, "Arista Laboratories" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator, "Covance IVRS" with 1 trials as a collaborator and "Pacific Biomarkers" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Covance CRU Inc." are "Arthritis" (2 trials), "Healthy" (2 trials), "Obesity" (2 trials), "Osteoarthritis" (2 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "Covance CRU Inc." in a lesser frequency.

Most popular intervention types in "Covance CRU Inc." are "Drug" (11 trials), "Biological" (4 trials), "Behavioral" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "tanezumab" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "AV650" (1 trials) and "Active comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Covance CRU Inc." are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Covance CRU Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Covance CRU Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Covance CRU Inc., 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".